← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE AND LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2016-09-29

Drug application

FDA Application #

ANDA079246

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABACAVIR SULFATE AND LAMIVUDINE

Generic name

Abacavir Sulfate

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

2016-09-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown